Company Filing History:
1 out of 676 
1 out of 274 
1 out of 832,891 Years Active: 2000-2001
Title: Nathalie Methot: Innovator in Eukaryotic Transcription
Introduction
Nathalie Methot is a prominent inventor based in Hull, Canada. She has made significant contributions to the field of molecular biology, particularly in the area of eukaryotic transcription. With a total of 2 patents, her work has implications for therapeutic methods in treating various disease states.
Latest Patents
Nathalie Methot's latest patents include innovations related to human Prt1-like subunit protein (hPrt1) polynucleotides. The first patent describes novel human Prt1 (hPrt1) and eIF4G-like (p97) proteins that are crucial for eukaryotic transcription. This invention provides isolated nucleic acid molecules encoding the human hPrt1 and p97 proteins. Additionally, it includes hPrt1 and p97 polypeptides, vectors, host cells, and recombinant methods for their production. The patent also outlines screening methods for identifying agonists and antagonists of hPrt1 and p97 activity, along with therapeutic methods for treating diseases associated with these proteins. The second patent similarly focuses on isolated human Prt1 protein, reiterating the importance of hPrt1 and p97 in transcription processes.
Career Highlights
Throughout her career, Nathalie Methot has worked with notable organizations, including Human Genome Sciences, Inc. Her research has been pivotal in advancing our understanding of transcription mechanisms in eukaryotic cells.
Collaborations
Nathalie has collaborated with esteemed colleagues such as Henrik S. Olsen and Steven M. Ruben, contributing to a rich exchange of ideas and innovations in her field.
Conclusion
Nathalie Methot's contributions to the field of molecular biology and her innovative patents highlight her role as a leading inventor in eukaryotic transcription. Her work continues to pave the way for advancements in therapeutic applications.